You can buy or sell Alector and other stocks, options, and ETFs commission-free!
Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA. The listed name for ALEC is Alector, Inc. Common Stock.
South San Francisco, California
52 Week High
52 Week Low
-$0.55 per share
-$0.67 per share